Establishment of a PDT Patient Registry
- Conditions
- First Posted Date
- 2018-07-17
- Last Posted Date
- 2020-02-24
- Lead Sponsor
- Concordia Laboratories Inc.
- Target Recruit Count
- 22
- Registration Number
- NCT03589456
- Locations
- 🇺🇸
University of Chicago, Chicago, Illinois, United States
🇺🇸Clinical Research Associates of Central PA, Altoona, Pennsylvania, United States
🇺🇸Medical University of South Carolina, Charleston, South Carolina, United States
Safety of PDT-Photofrin® Prior to Lung Surgery
- Conditions
- Interventions
- First Posted Date
- 2017-11-17
- Last Posted Date
- 2020-01-13
- Lead Sponsor
- Concordia Laboratories Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT03344861
- Locations
- 🇺🇸
Moffitt Cancer Center, Tampa, Florida, United States
🇺🇸Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸University of Colorado, Denver, Colorado, United States
Feasibility Study of Using Navigational Bronchoscopy to Perform PDT-Photofrin® in Unresectable Peripheral Lung Cancer
- Conditions
- Interventions
- First Posted Date
- 2016-09-27
- Last Posted Date
- 2020-03-04
- Lead Sponsor
- Concordia Laboratories Inc.
- Target Recruit Count
- 5
- Registration Number
- NCT02916745
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
🇺🇸Southeastern Regional Medical Center, Atlanta, Georgia, United States
🇺🇸Providence Medical Research Center, Spokane, Washington, United States
Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)
- Conditions
- Interventions
- First Posted Date
- 2014-03-10
- Last Posted Date
- 2019-08-28
- Lead Sponsor
- Concordia Laboratories Inc.
- Target Recruit Count
- 28
- Registration Number
- NCT02082522
- Locations
- 🇨🇦
CHUM Hôpital St-Luc, Montreal, Quebec, Canada
🇺🇸University of Southern California Keck School of Medicine, Los Angeles, California, United States
🇺🇸UC Davis Medical Center, Sacramento, California, United States